Assessing Renal Impairment in Treatment-Naïve Adolescents Living with HIV Commencing Antiretroviral Therapy In Zimbabwe.
Options
BORIS DOI
Date of Publication
April 1, 2023
Publication Type
Article
Division/Institute
Contributor
Byers, Bradley W | |
Drak, Douglas | |
Chimbetete, Cleophas | |
Dahwa, Rumbidzai | |
Gracey, David M |
Series
AIDS
ISSN or ISBN (if monograph)
1473-5571
Publisher
Wolters Kluwer Health
Language
English
Publisher DOI
PubMed ID
36728249
Description
OBJECTIVE
People living with HIV (PLWHIV) are increasingly experiencing non-communicable complications, including renal impairment, which are associated with worse clinical outcomes. Limited information exists surrounding renal impairment in paediatric PLWHIV, of which the majority live in sub-Saharan Africa, and further information is required to guide clinical practice. This study describes the prevalence of new or worsening renal impairment in adolescents commencing antiretroviral therapy (ART) in Zimbabwe and associated risk factors.
DESIGN
Retrospective cohort study.
METHODS
Data were collected between January 2010 to January 2019 from the medical records of adolescents aged 12-17 years initiating ART at an outpatient HIV clinic in Zimbabwe. Renal function (eGFR) was calculated using the Full Age Spectrum formula. Proteinuria was defined as a single urine dipstick score of ≥1+. Potential predictors of renal impairment at follow-up were assessed by logistical regression.
RESULTS
266 adolescents were included in analysis. Baseline renal impairment (eGFR <90 ml/min/1.73m2) and proteinuria were present in 13% and 7% of the cohort, respectively. After a median of 4.1 years (IQR 1.9, 6.9) following ART commencement, mean eGFR increased by 10 ml/min/1.73m2 (p < 0.01), and the prevalence of renal impairment decreased to 8% (p < 0.01). Baseline renal impairment predicted renal impairment at follow-up (OR 8.98; 95%CI 2.81, 28.68; p < 0.01). Proteinuria trended towards association with renal impairment at follow-up (OR 4.39; 95%CI 0.95, 20.31; p = 0.06).
CONCLUSIONS
Renal impairment is common in adolescent ART-naïve PLWHIV, and baseline renal impairment is associated with longstanding renal impairment, while baseline proteinuria trended towards an association with longstanding renal impairment.
People living with HIV (PLWHIV) are increasingly experiencing non-communicable complications, including renal impairment, which are associated with worse clinical outcomes. Limited information exists surrounding renal impairment in paediatric PLWHIV, of which the majority live in sub-Saharan Africa, and further information is required to guide clinical practice. This study describes the prevalence of new or worsening renal impairment in adolescents commencing antiretroviral therapy (ART) in Zimbabwe and associated risk factors.
DESIGN
Retrospective cohort study.
METHODS
Data were collected between January 2010 to January 2019 from the medical records of adolescents aged 12-17 years initiating ART at an outpatient HIV clinic in Zimbabwe. Renal function (eGFR) was calculated using the Full Age Spectrum formula. Proteinuria was defined as a single urine dipstick score of ≥1+. Potential predictors of renal impairment at follow-up were assessed by logistical regression.
RESULTS
266 adolescents were included in analysis. Baseline renal impairment (eGFR <90 ml/min/1.73m2) and proteinuria were present in 13% and 7% of the cohort, respectively. After a median of 4.1 years (IQR 1.9, 6.9) following ART commencement, mean eGFR increased by 10 ml/min/1.73m2 (p < 0.01), and the prevalence of renal impairment decreased to 8% (p < 0.01). Baseline renal impairment predicted renal impairment at follow-up (OR 8.98; 95%CI 2.81, 28.68; p < 0.01). Proteinuria trended towards association with renal impairment at follow-up (OR 4.39; 95%CI 0.95, 20.31; p = 0.06).
CONCLUSIONS
Renal impairment is common in adolescent ART-naïve PLWHIV, and baseline renal impairment is associated with longstanding renal impairment, while baseline proteinuria trended towards an association with longstanding renal impairment.
File(s)
| File | File Type | Format | Size | License | Publisher/Copright statement | Content | |
|---|---|---|---|---|---|---|---|
| Assessing_Renal_Impairment_in_Treatment_Na_ve.188.pdf | text | Adobe PDF | 656.82 KB | publisher | accepted | ||
| Byers_AIDS_2023.pdf | text | Adobe PDF | 542.33 KB | publisher | published |